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Summary
We screened for the impact of hyperthermal regimes varying in the cumulative
equivalent minutes at 43°C (CEM43°C) and media composition on tumour devel-
opment using an original teratoma in vitro model. Rat embryos (three germ lay-
ers) were microsurgically isolated and cultivated at the air-liquid interface. During
a two week period, ectodermal, mesodermal and endodermal derivatives devel-
oped within trilaminar teratomas. Controls were grown at 37°C. Overall growth
was measured, and teratoma survival and differentiation were histologically
assessed. Cell proliferation was stereologically quantified by the volume density
of Proliferating Cell Nuclear Antigen. Hyperthermia of 42°C, applied for 15 min-
utes after plating (CEM43°C 3.75 minutes), diminished cell proliferation
(P ˂ .0001) and enhanced differentiation of both myotubes (P ˂ .01) and cylin-
drical epithelium (P ˂ .05). Hyperthermia of 43°C applied each day for 30 min-
utes during the first week (CEM43°C 210 minutes) impaired overall growth
(P ˂ .01) and diminished cell proliferation (P ˂ .0001). Long-term hyperthermia
of 40.5°C applied for two weeks (CEM43°C 630 minutes) significantly impaired
survival (P ˂ .005). Long-term hyperthermia of 40.5°C applied from the second
day when differentiation of tissues begins (CEM43°C 585 minutes) impaired sur-
vival (P ˂ .0001), overall growth (P ˂ .01) and cartilage differentiation
(P ˂ .05). No teratomas survived extreme regimes: 43°C for 24 hours (CEM43°C
1440 minutes), hyperthermia in the scant serum-free medium (CEM43°C
630 minutes) or treatment with an anti-HSP70 antibody before long-term hyper-
thermia 40.5°C from the second day (CEM43°C 585 minutes). This in vitro
research provided novel insights into the impact of hyperthermia on the develop-
ment of experimental teratomas from their undifferentiated sources and are thus
of potential interest for future therapeutic strategies in corresponding in vivo
models.
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1 | INTRODUCTION
Contemporary thermal therapy of cancer aims at the tar-
geted destruction of the tumour and is usually used as an
adjuvant therapy.1-3 It is also important to avoid normal tis-
sue damage that can or cannot be caused by different ther-
mal exposures.4 To calculate a thermal isoeffect dose, the
cumulative equivalent minutes at 43°C (CEM43°C) was
introduced and used in studying the thermal damage in var-
ious systems.4-6 For in vitro systems, CEM43°C can be
easily calculated, but for a number of biological, physiolog-
ical and technical reasons, it is still difficult to apply
CEM43°C for mild hyperthermia treatment monitoring
in vivo at temperatures between 40 and 44°C (as reviewed
by van Rhoon).7
Recently, hyperthermia was proposed to specifically tar-
get cancer stem cells.8 As cancer stem cells seem to be the
most resistant to conventional therapy, it is important to
develop new strategies to combat them.9,10 Indeed, malig-
nancies may develop not only as the consequence of gene
mutations but also as a result of epigenetically deregulated
development of stem cells of which germ cell tumours are
the best example.11-13 Therefore, at this crossroad between
normal and tumour development, it is important to be
aware of the influence of hyperthermia on different devel-
opmental processes in order to design adequate and appro-
priate hyperthermal regimes for the therapy of cancer.
Hyperthermia has been shown to induce malformations in
numerous animal models and has been associated with
human abnormalities, but the precise molecular mechanism(s)
for translation into specific cellular functions remains
largely unknown.14,15
In vivo experimental studies on animals provided data
about the type of malformations caused by exposure to the
heat, the most sensitive developmental stages and the criti-
cal doses for the teratogenic effect of heat.16-19
In vivo studies on animals were not so accurate because
of the variability in the developmental stages found in a
female and the quantity of heat affecting an embryo
through the heating of the mother. By the in vitro
approach, such problems and the influence of the mother’s
metabolic response could be omitted.20 In the whole rat
in vitro culture (WEC) used as an alternative to in vivo
experiments in animals,21 malformations of the brain,
face and eyes were found and the temperature thresholds
were defined during the short-term (2-day) culture
in vitro.22-25
In an original experimental teratoma model in vitro, it
was possible to screen for embryotoxic or teratogenic sub-
stances during rat development,11,26,27 and also reduce the
need for screening experiments in living animals accord-
ingly to the 3Rs of Russel and Burch.21 In this model, the
development starts at the most critical period of
development (gastrulation) when the embryo consists of
the 3 germ layers containing only stem cells for the 3 basic
cell lineages (ectodermal, mesodermal, endodermal). Devel-
opment is followed up to 2 weeks in vitro, which is longer
than in WEC, and simultaneous assessment of several end-
points such as the survival, overall growth, cell prolifera-
tion and differentiation is possible. This model also has an
advantage over various cell cultures because it is a natural
3D system where tissue interactions are not as disrupted as
in cell cultures.
Our aim was now to assess the impact of hyperthermal
regimes varying in the cumulative equivalent minutes at
43°C (CEM43°C) and media composition upon the devel-
opment of the experimental teratoma during 2 weeks
in vitro to discover the most pronounced effects that could
be proposed for the therapy of malignancies in correspond-
ing models in vivo.11
2 | MATERIAL AND METHODS
2.1 | Ethical statement
All procedures with animals were conducted according to
the Directive 2010/63/EU and Croatian Law on protection
of experimental animals. They were approved by the Ethi-
cal Committee of the School of Medicine, University of
Zagreb, Croatia.
2.2 | Animals
Fisher inbred strain rats were kept in conventional cages,
with standard diet and water ad libitum. Three months old
females were mated with males overnight, and noon of the
following day was assigned as the 0.5 day of pregnancy if
sperm was found in the vaginal smear. At least four
females were chosen for each experimental group.
At 9.5 dpc, pregnant rat females were anesthetized with
0.8 mL/kg of ketamine (Narketan; Vetoquinol, Bern,
Switzerland) and 0.6 mL/kg of xylazine (Xylapan; Veto-
quinol). Uteruses were removed, and animals were sacri-
ficed by this procedure. All deciduas were removed from
the uteruses. Under the dissecting microscope, egg cylin-
ders were isolated from deciduas with watchmaker’s for-
ceps, and Reichert’s membranes and ectoplacental cones
were removed. Then, the extraembryonic part was cut away
at the level of the amnion leaving just the embryo proper
consisting of the three germ layers.
2.3 | In vitro culture
All isolated embryos were randomly divided into respective
experimental or control groups and plated in vitro. In each
culture dish, three explanted embryos were placed on a lens
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paper supported by a stainless steel grid placed in a
60 9 15 mm centre-well of an organ culture dish (BD Fal-
conTM, Oxford, UK) and culture medium was added to the
well to wet the lens paper. Explants were grown in Eagle’s
minimum essential medium (MEM) with 50% of rat serum
at the air-liquid interface. The serum was collected from
the blood of anesthetized male rats (0.8 mL/kg of ketamine
(Narketan; Vetoquinol) and 0.6 mL/kg of xylazine (Xyla-
pan; Vetoquinol) of the same strain and heat inacti-
vated.28 For serum-free culture conditions, MEM was
supplemented with 50 lg/mL of human holo-transferrin
(Sigma, St. Louis, MO, USA). Control explants were
grown in an incubator at 37°C for 2 weeks. Cultures were
grown in 5% CO2 and 95% humidified air. The medium
was changed on alternate days for two weeks.
2.4 | Hyperthermal regimes
Explanted embryos were cultivated in hyperthermal condi-
tions in a separate incubator precalibrated one day before
to the elevated temperature. After exposure to hyperther-
mia, explants were returned to another incubator at 37°C
where control explants were cultivated from the beginning
of culture.
If the sample was heated in n time intervals i = 1. . .n,
and each time interval is at the temperature Ti, then the
cumulative equivalent minutes at 43°C (CEM43°C) was cal-
culated using CEM43C ¼ P
n
i¼1
CEM43Ci where the contri-
bution of the i-th interval of length Dti at constant
temperature Ti is given by the relation CEM43Ci ¼ Dti
R43Ti where R ¼ RðTÞ ¼ 14 ; T\43
 
; 12 ; T[ 43
  
.6
Alternatively, we write CEM43Ci ¼ Dti  XTi43, where
X ¼ XðTÞ ¼ 4; T\43ð Þ; 2; T[ 43ð Þf g.
Explanted embryos were subjected to short-term
hyperthermia at 42°C for 15 minutes (CEM43°C
3.75 minutes). The second group of explants was sub-
jected either to 43°C (5°C higher than the normal rat
body temperature) for 30 minutes every day during the
first 7 days of culture (CEM43°C 210 minutes) or con-
tinuously during the first 24 hours of culture (CEM43°C
1440 minutes).
In the long-term hyperthermia experiments, explants
were exposed to the milder temperature at 40.5°C. The first
group was exposed to 40.5°C during whole 2 weeks of
culture (CEM43°C 630 minutes) in Eagle’s minimum
essential medium supplemented with 50% rat serum or in
serum-free conditions with 50 lg/mL of holo-transferrin
(T0665; Sigma) added to MEM.29 The second group was
treated with 40.5°C from the second day of culture until
the end of the culture period (CEM43°C 585 minutes) in
MEM supplemented with 50% rat serum. The third group
was treated with one dose of 100 lL/mL of antibody to
heat shock protein 70 (HSP70; AM289-5M; Biogenex, San
Ramon, USA) before exposure to mild temperature from
the second day (CEM43°C 585 minutes).
2.5 | Overall growth
The overall growth of all isolated explants was followed
from the moment of plating explanted embryos throughout
the two week culture period during which teratomas are
developing.30 Measures were included in the formula for
ellipse area (A = p 9 major diameter 9 minor diameter/4).
All values were normalized by the division to values of the
initial measurement and used as the measure of overall
growth (A/A0) as described before.
31 Therefore, A/A0 was 1
for the day 0 when the explants were plated at the
air-liquid surface.
2.6 | Histology and immunohistochemistry
After two weeks of culture, experimental teratomas were
placed for 24 hours into mild St. Marie fixative solution
(1% glacial acetic acid in 96% EtOH), dehydrated and
embedded in paraffin. Uninterrupted or serial step sec-
tions (5 lm) were prepared and processed for routine
histology or immunohistochemistry. For histological anal-
ysis of survival and differentiation, haematoxylin-eosin-
stained sections were used as previously described.32
For immunohistochemistry, several teratomas were cho-
sen at random from the control and experimental regimes.
For single immunohistochemical labelling, Animal
Research Peroxidase Kit (Dako, Glostrup, Denmark) was
used according to the manufacturer’s instructions. Briefly,
microscopic slides with serial sections were deparaffinized,
cleared in xylene and hydrated to PBS in gradient alcohols.
Antigen retrieval was performed in Dako Target Retrieval
Buffer pH = 6.0 in a microwave oven on 700 W. After
boiling, slides were cooled for one minute, which was
repeated three times. Slides were then cooled for 20 min-
utes, blocked with Peroxidase Blocking reagent (0.03%
H2O2) for five minutes and rinsed three times in PBS. Pri-
mary antibodies were diluted in 1% BSA/PBS and incu-
bated for 15 minutes with Biotinylation Reagent and
five minutes with Blocking Reagent. Primary antibodies
used in this study were mouse anti-human Proliferating
Cell Nuclear Antigen (PCNA) monoclonal antibody (Clone
PC-10; M0879; 1:100; Dako), mouse anti-rat nestin mono-
clonal antibody (Rat 401; Developmental Studies Hybri-
doma Bank, Iowa, IA; 1:5) or mouse anti-Neurofilament
160 kDa (anti-NF160) monoclonal antibody (N-5264;1:20;
Sigma). Slides were incubated with primary antibody for
one hour, washed three times for five minutes with PBS
and incubated for 15 minutes with Dako streptavidin-horse-
radish peroxidase complex. Visualization of the signal was
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performed with DAB (3,30-diaminobenzidine) and chro-
mogen-substrate complex for one minute and stopped in
dH2O. Slides were contrasted with haematoxylin, washed
with tap water for 20 minutes and covered with glycerol/
PBS solution (1:1).
For double immunolabelling, En Vision Doublestain kit
(Dako) was used. Staining with anti-rat nestin monoclonal
antibody was performed as described above, but after
being treated with DAB, slides were washed for five min-
utes in H2O and blocked for 10 minutes with En Vision
Doublestain Block Reagent. Primary antibody to PCNA
(1:100; Dako) and monoclonal mouse anti-human glial fib-
rillary acidic protein (GFAP) antibody (N 1506; Dako
Ready-To-Use) or anti-nestin antibody were diluted in 1%
BSA/PBS and applied on slides for one hour. Slides were
washed three times for five minutes with PBS and incu-
bated with alkaline phosphatase-labelled polymer for
15 minutes. After washing for three times in PBS, Fast
Red and chromogen-substrate for alkaline phosphatase
were applied for five minutes. The reaction was stopped
after one minute in dH2O, after which the slides were con-
trasted with haematoxylin, washed in tap water, dehydrated
and covered with glycerol/PBS solution (1:1).
2.7 | Stereology
Step serial sections of complete explants that were
immunohistochemically stained with an antibody to PCNA
were quantified by estimating the volume density of
PCNA-positive cells in the sections of control and experi-
mental explants. The analysis was performed under the
Nikon Alphaphot binocular light microscope (Nikon,
Vienna, Austria) using Weibel’s M42 test system, made of
42 short test lines each with two ends as test points.33 Vol-
ume density of PCNA-positive cells was estimated by
counting points of the test system, which hit PCNA-stained
nuclei, and points which hit the reference space at the mag-
nification of 400 9 (reference space being defined as hits
on any part of an explant). Volume density (Vv) of PCNA
is the ratio between the hits falling in all PCNA-stained
nuclei (Pi) and hits falling in the reference space (Pt;
Vv = Pi/Pt), and is expressed in mm
0 (mm3/mm3).33,34
Before analysis, for each experimental group, the stereolog-
ical orientation measurement was carried out to define the
number of fields to be tested.34 At least 90 fields were
stereologically assessed.
2.8 | Statistical analysis
Statistics were performed by an SPSS Statistics 10.0
(SPSS, Chicago, IL, USA) and GraphPad Prism 5.01
(GraphPad Software, Inc., San Diego, CA, USA).
Descriptive analysis was made for all data, and the nor-
mal distribution was tested by Kolmogorov-Smirnov test or
Shapiro-Wilk test after which parametric or nonparametric
tests were chosen to compare variances.
The overall growth of explants assessed as described
above was tested by parametric t test or one-way analysis
of variance (ANOVA) or nonparametric Kruskal-Wallis or
Mann-Whitney U test. For survival and differentiation anal-
ysis, proportions of survived explants or differentiated tis-
sues in experimental teratomas were compared by either
chi-square test or Fisher’s exact test.
Differences in the volume density of PCNA-positive
cells were tested using Student’s t test or one-way ANOVA
with the post hoc Tukey’s multiple comparison test.
The statistical significance level was P < .05.
3 | RESULTS
3.1 | Survival
3.1.1 | Short-term hyperthermia
In the first part of the screening, experiments were carried
out with hyperthermia of duration shorter than the two
week culture period and at higher temperatures (Table 1).
Almost all explanted embryos survived for two weeks
when the temperature of 42°C was applied for the short
period of 15 minutes at the beginning of culture
(CEM43°C 3.75 minutes).
To test the ability for survival in more severe hyperther-
mal conditions, two experiments on a smaller number of
explants were conducted. First, 43°C was applied for
30 minutes each day during 7 days (CEM43°C 210 min-
utes). Surprisingly, the survival was the same as in con-
trols. However, when explants were treated with 43°C for
TABLE 1 Experimental teratoma survival after 14 d of in vitro
culture in short hyperthermal regimes. After the two week culture,
survival was assessed by classical histology. All teratomas survived in
controls and in the hyperthermal regime at 43°C for 30 min during
7 d. Note that at 43°C applied for 24 h no teratomas survived, which
was significantly different in comparison with controls
Regime
37°C 42°C 150
43°C
300/7 d
43°C
24 h
CEM43°C
(min)
Control 3.75 210 1440
N % N % N % N %
Explanted
embryos
122 100 109 100 19 100 12 100
Teratomas
developed
in vitro
122a 100 107 98.2 19 100 0a 0
Fisher’s exact test: aP < .0001.
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24 hours (CEM43°C 1440 minutes), survival was impaired
to the extent that no teratomas for the histological analysis
were obtained.
3.1.2 | Long-term hyperthermia
In the second part of the screening, experiments were
carried out with milder hyperthermia of 40.5°C but
applied for a longer time (long-term hyperthermia;
Table 2). To test the response to hyperthermia with the
stage of teratoma development, hyperthermia was applied
either from the first day (CEM43°C 630 minutes) or the
second day of culture (CEM43°C 585 minutes). The sur-
vival was significantly lower in both groups treated with
40.5°C in comparison with controls. Previously applied,
the antibody to HSP70 completely disabled survival of
explants treated with hyperthermia from the second day
(CEM43°C 585 minutes).
Long-term hyperthermia (40.5°C) applied from the start
of culture (CEM43°C 630 minutes) caused complete necro-
sis of the serum-free cultivated explants (Table 3).
3.2 | Overall growth
3.2.1 | Short-term hyperthermia
The explants treated once with 42°C for a short period of
15 minutes (CEM43°C 3.75 minutes) were surprisingly lar-
ger than controls on days 5 and 9 (Figure 1A).
Hyperthermia of 43°C severely affected overall growth of
experimental teratomas, which were smaller than controls
during the whole culture period (Figure 1B). Treatment with
43°C for 24 hours leads to a significant decrease in size on
the fifth day of culture (CEM43°C 1440 minutes). The group
treated at 43°C for 30 minutes during the first seven days
(CEM43°C 210 minutes) showed a smaller, although still
significant decrease, starting at the same day, till the end of
the culture period. Therefore, comparison between the
groups treated with 43°C showed that the group treated peri-
odically during seven days for 30 minutes was significantly
larger than the group treated once for 24 hours.
3.2.2 | Long-term hyperthermia
When explants were treated with 40.5°C from the start of
the culture (CEM43°C 630 minutes), no difference in the
overall growth during the whole culture period was
detected in comparison with controls. However, when trea-
ted with 40.5°C from the second day (CEM43°C 585 min-
utes), they were significantly smaller than controls during
the whole culture period but also smaller than the group
treated on 40.5°C from the start (CEM43°C 630 minutes;
Figure 2A).
When the antibody to heat shock protein HSP70 was
added to the medium on the second day before long-term
hyperthermia, explants have shown a decrease in size
already in the first week of culture (CEM43°C 585 min-
utes). They were significantly smaller compared to control
and also to those treated with hyperthermia without the
antibody (Figure 2A).
TABLE 2 Experimental teratoma survival after 14 d of in vitro culture in long hyperthermal regimes at 40.5°C. After the two week culture,
survival was assessed by classical histology. Almost all teratomas survived in controls while in the hyperthermal regime at 40.5°C from both the
first, and the second day, survival was significantly impaired in comparison with controls. Note that at 40.5°C from the second day with the
addition of antibody against HSP70 no teratomas survived which was significantly different in comparison with controls
Regime
37°C
40.5°C from
second day
40.5°C from
second
day + anti-
HSP70 40.5°C
CEM43°C (min) Control 585 585 630
N % N % N % N %
Explanted embryos 59 100 29 100 8 100 27 100
Teratomas developed in vitro 58a,b,c 98.31 24a 82.76 0b 0 20c 74.07
Fisher’s exact test: aP < .05; bP < .0001, cP < .005.
TABLE 3 Experimental teratoma survival after 14 d of in vitro
culture in the serum-free medium (MEM supplemented with 50 lg/
mL human holo-transferrin) in a long hyperthermal regime at 40.5°C.
After the two week culture, survival was assessed by classical
histology. Note that only a portion of teratomas cultivated in the
chemically defined medium with transferrin (controls) survived, while
in the hyperthermal regime at 40.5°C no teratomas survived which
was significantly different in comparison with controls
Regime
37°C in
MEM +
transferrin
40.5°C in
MEM +
transferrin
CEM43°C (min) Control 630
N % N %
Explanted embryos 34 100 37 100
Teratomas developed in vitro 22a 64.71 0a 0
Fisher’s exact test: aP < .0001.
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FIGURE 1 Overall growth of
teratomas in short-term hyperthermal
regimes (mean  SEM). A/A0 - explant
area/explant area at the beginning of
culture. A, Growth of teratomas in short-
term hyperthermal regime at 42°C
(CEM43°C 3.75 min) was significantly
higher during the first part of the culture in
comparison with controls cultivated at
37°C. Student’s t test: ***P < .0001; B,
growth of explants in short-term
hyperthermal regimes at 43°C. Note that at
43°C for 30 min during 7 d (CEM43°C
210 min), growth was significantly lower
than in controls cultivated at 37°C, while at
43°C applied for 24 h (CEM43°C
1440 min) growth was even lower.
ANOVA: *P < .01; ***P < .0001
FIGURE 2 Overall growth of
teratomas in long-term hyperthermal
regimes (mean  SEM). A/A0 - explant
area/explant area at the beginning of
culture. A, Growth of explants in the
serum-supplemented medium in the
hyperthermal regime at 40.5°C from the
first day (CEM43°C 630 min) was as in
controls and that was significantly higher
than in the hyperthermal regime at 40.5°C
from the second day (CEM43°C 585 min).
Note that growth of teratomas at 40.5°C
from the second day with the addition of
antibody against HSP70 (CEM43°C
585 min) was the lowest and significantly
different in comparison with controls and
the two other regimes at 40.5°C. ANOVA:
**P < .001; ***P < .0001; B, growth of
teratomas in the chemically defined
medium with transferrin as the only protein
was significantly lower during the first
week at 40.5°C (CEM43°C = 630 min) in
comparison with controls cultivated at
37°C. Student’s t test: ***P < .0001
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As expected, in the chemically defined serum-free med-
ium explants were always smaller than those cultivated
with serum.29 Exposure to long-term hyperthermia (40.5°C;
CEM43°C 630 minutes) significantly decreased explant
growth in comparison with controls, especially in the first
week (Figure 2B).
3.3 | Differentiation and cell proliferation
In the control and experimental hyperthermal regimes, all
surviving embryonic explants developed into teratoma-like
structures. By light microscopy, differentiated tissues
among which ectodermal derivatives such as epidermis and
neural tissue (Figure 3), mesodermal derivatives such as
myotubes and cartilage (Figure 4) and endodermal deriva-
tive, the columnar epithelium (Figure 5) were easily
detected after the two week culture period. Stratified squa-
mous epithelium (epidermis) contained basal and supraba-
sal keratinocytes with exfoliated keratin at the top
(Figure 3A,B). Cells of the stratum germinativum, for
example basal cells situated next to basement membrane
and cells of the stratum spinosum, the second layer of epi-
dermal cells, were positive for the proliferating cell nuclear
antigen (PCNA; Figure 3B), as expected. Neural tissue
contained typical big light nuclei scattered within the neu-
ropil (Figure 3A). Within the neural tissue, some cells
expressed cell proliferation marker PCNA (Figure 3C,E).
Nestin, a neural stem cell marker but also a marker of
(A) (B)
(C) (D)
(E) (F)
FIGURE 3 Differentiation of ectodermal derivatives and ability for cell proliferation in teratomas after two weeks of in vitro culture.
A, Keratinized epidermis (E) and neural tissue (N) in a teratoma in vitro developed after 14 d of culture on 40.5°C (CEM43°C 630 min;
HE). B, PCNA expression in the nuclei of epidermal cells (arrow) after a two week hyperthermia on 40.5°C starting from the 2nd day
(CEM43°C 585 min). Note the basement membrane (arrowhead) and well-developed epidermal cell layers: stratum basale (SB), stratum
spinosum (SS) and stratum granulosum (SG). C, PCNA expression (arrow) in nuclei of neural tissue cells found after two weeks of
hyperthermia on 40.5°C (CEM43°C 630 min) starting from the second day. Note that majority of neuroblasts are negative for proliferation
marker (arrowhead). IHC, DAB, counterstained by haematoxylin. D, Expression of nestin (arrow) in neural tissue developed after treatment
with 43°C for 30 min daily for seven days. (CEM43°C = 210 min). IHC, DAB, counterstained by haematoxylin. E, Expression of GFAP
(arrow) and PCNA (arrowhead) in neural tissue after a two week hyperthermia at 40.5°C (CEM 43°C = 630 min). IHC, double
immunolabelling, DAB, Fast Red, counterstained by haematoxylin. F) Neurons containing neurofilaments (arrow) in the neural tissue of a
control cultivated at 37°C. IHC, DAB, counterstained by haematoxylin [Colour figure can be viewed at wileyonlinelibrary.com]
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specific neurons in the adult brain,35 was also expressed,
surrounding only a few cells within the neural tissue (Fig-
ure 3D). Markers of neural tissue differentiation, glial fib-
rillary acidic protein (GFAP; Figure 3E) and
neurofilaments (NF; Figure 3F) were also detected. Myo-
tubes, precursors of the skeletal muscle, typically contained
several nuclei in a row (Figure 4A) and were expressing
nestin (Figure 4B). Cartilage contained typical chondrob-
lasts with elongated cell shape in the zone of appositional
growth, while chondrocytes were typically situated in
lacunae embedded in the extracellular matrix. Chondro-
cytes, in the zone of interstitial growth, were characterized
by the formation of isogenic groups typically containing at
least two cells within a single lacuna (Figure 4C). PCNA
was abundantly expressed in nuclei of cartilage cells (Fig-
ure 4D). Simple columnar epithelium typically expressed
PCNA in the majority of cells (Figure 5A). Nestin expres-
sion was abundant in the vicinity of the columnar gut-like
epithelium, sometimes connecting several small cells which
were reminiscent of the enteric ganglia (Figure 5B).
(A) (B)
(C) (D)
FIGURE 4 Differentiation of mesodermal derivatives (myotubes and cartilage) and ability for cell proliferation in teratomas after 2 wk of
in vitro culture. A, Myotubes with several nuclei (arrow) found in a teratoma in vitro after hyperthermia of 42°C applied for 15 min (CEM43°C
3.75 min; HE). B, Perinuclear nestin expression in differentiated myotubes (arrow) after hyperthermia of 43°C for 30 min (CEM43°C 210 min)
during 7 d. IHC, DAB, counterstained by haematoxylin. C, Cartilage with chondroblasts (arrow), chondrocytes situated in lacunae (dashed arrow)
and isogenic groups of chondrocytes (arrowhead) after a two week hyperthermia on 40.5°C starting from the second day (CEM43°C 585 min; HE).
D, Expression of PCNA (arrow) in the cartilage (C), in some cells of the neural tissue (N) and epidermis (E) and expression of nestin (arrowhead) in
teratoma treated with 42°C for 15 min (CEM43°C 3.75 min). IHC, double immunolabelling, Fast Red, DAB, counterstained by haematoxylin
[Colour figure can be viewed at wileyonlinelibrary.com]
(A) (B)
FIGURE 5 Differentiation of endodermal derivative, the columnar epithelium and ability for cell proliferation in teratomas after two weeks
of in vitro culture. A, PCNA expression (arrowhead) in nuclei of the columnar epithelium cells (arrow). Note also the PCNA expression in
adjacent neural tissue forming rosettes (R) in an explant treated with hyperthermia of 43°C for 30 min during 7 d (CEM43°C 210 min). IHC,
DAB, counterstained by haematoxylin. B, Columnar epithelium (CE) and nestin expression (arrow) in enteric ganglia-like structures of a control
cultivated at 37°C. IHC, DAB, counterstained by haematoxylin [Colour figure can be viewed at wileyonlinelibrary.com]
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3.3.1 | Short-term hyperthermia
In explanted embryos treated with 42°C for 15 minutes
(CEM43°C 3.75 minutes), myotubes (Figure 4A) and
columnar epithelium differentiated with significantly higher
incidence than in controls (Table 4). PCNA expression was
present, but the volume density was the lowest and signifi-
cantly different in comparison with controls (Figure 6).
In experimental teratomas resulting from the periodical
treatment with 43°C for 30 minutes during first 7 days of
culture (CEM43°C 210 minutes; Table 5), PCNA (Fig-
ure 5A) and nestin (Figures 3D and 4B) expression was dis-
tributed as has been described above. However, the volume
density of PCNA-labelled cells at the end of culture was sig-
nificantly reduced in comparison with controls (Figure 6).
3.3.2 | Long-term hyperthermia
In both long-term hyperthermia regimes at 40.5°C, differ-
entiated tissues were detected. In the group of embryos
treated with 40.5°C after the first 24 hours of culture
(CEM43°C 585 minutes), differentiation of cartilage was
significantly impaired (Table 6), while in the group treated
from the start of the culture (CEM43°C 630 minutes), this
impairment was not significant (Table 7).
PCNA expression was still observed after long-term
hyperthermia (Figure 3B,C,E). In both long-term hyper-
thermia experiments, PCNA expression (Vv) was not
significantly changed in comparison with controls and
no difference in PCNA expression between the two
treatments on 40.5°C (from the first or the second day
of culture) could be found (Figure 6).
TABLE 4 Experimental teratoma differentiation in a short
hyperthermal regime at 42°C for 15 min at the beginning of culture.
After the two week culture, differentiation in teratomas was assessed
by classical histology. Note that in the hyperthermal regime at 42°C
applied for 15 min the incidence of myotubes and columnar
epithelium was significantly higher than in controls at 37°C
Regime
37°C 42°C 150
CEM43°C (min) Control 3.75
N % N %
Teratomas developed in vitro 77 100 93 100
Epidermis 71 92.21 86 92.47
Neural tissue 65 84.42 77 82.80
Cartilage 66 85.71 74 79.57
Myotubes 48a 62.34 75a 80.65
Columnar epithelium 70b 90.91 92b 98.92
Chi-square test: aP < .01; Fisher’s exact test: bP < .05.
FIGURE 6 Volume density (Vv) of PCNA-positive cells in hyperthermal regimes. No difference in cell proliferation was discovered in
hyperthermal regimes at 40.5°C (CEM43°C 630 min, from 1st day and CEM43°C 585 min, from the second day) in comparison with controls.
Note significantly lower cell proliferation ability in hyperthermal regimes at 43°C for 30 min (CEM43°C 210 min) during seven d and 42°C for
15 min (CEM43°C 3.75 min) in comparison with controls. Mann-Whitney U test: ***P < .0001
TABLE 5 Experimental teratoma differentiation in a short
hyperthermal regime at 43°C applied for 30 min during the first week
of culture. After the 2-wk culture, differentiation in teratomas was
assessed by classical histology. No differences in the tissue incidence
were observed between controls cultivated at 37°C and those
cultivated at 43°C for 30 min during 7 d
Regime
37°C 43°C 300 7 d
CEM43°C (min) Control 210
N % N %
Teratomas developed in vitro 11 100 6 100
Epidermis 11 100 6 100
Neural tissue 10 90.91 6 100
Cartilage 9 81.82 3 50.00
Myotubes 10 90.91 6 100
Columnar epithelium 11 100 6 100
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4 | DISCUSSION
Results of screening for the impact of hyperthermia on the
experimental teratomas developed from gastrulating embryos
that contained only the stem cells for three basic lineages
(ectodermal, mesodermal and endodermal) were positive for
every hyperthermal regime that we applied (40.5-43°C)
where CEM43°C was in the range from 3.75 to 1440 min-
utes. Therefore, this in vitro model seems to be as sensitive
to this externally applied physical factor as it was to various
biologically active substances, among which a DNA-
demethylating agent (5-azacytidine) used today in the ther-
apy of myelodysplastic syndrome.26,27 We may suppose that
the similar effects may be obtained at least in the experimen-
tal teratoma model in vivo that originates from transplanted
embryos to an ectopic environment.11 In 2011, Yarmolenko
et al reviewed CEM43°C and thermal threshold damage data
(≥20 - 1.5 9 104 minutes) mostly in rodent models and
found that they are different for various tissues and species.
In 2016, van Rhoon states that clinical trials aspire to use
43°C but probably achieve 39.5-41°C for 69-90 minutes. As
reviewed by Seifert et al,36 in 2016, adjuvant hyperthermia
was used in paediatric patients for treatment of refractive or
recurrent sarcomas and germ cell tumours. In a study on 35
children with germ cell tumours, 86% had an objective
response to treatment with combination of one hour regional
deep hyperthermia (41-43°C) on days 1 and 4 and
chemotherapy.37 Indeed, hyperthermia, either localized,
regional or whole-body hyperthermia, has been used in clini-
cal trials to destroy various tumours or impede their growth.
Usually, it is regarded as an adjuvant therapy for radiother-
apy and chemotherapy because it causes secondary changes
that increase susceptibility of tumour tissue to destruction,
but more studies are needed to identify hidden effects of
hyperthermia as reviewed by Behrouzkia et al.38
Although parameters of development were almost
always negatively affected in our in vitro study with exper-
imental teratomas, the experiment at the 42°C for 15 min-
utes did not affect survival and at the beginning even
increased the growth of explants. These results differ from
in vivo studies where the temperature of 42°C applied for
10 minutes caused resorptions.16 In WEC, after 2 days, this
dose caused only mild retardation of development but sev-
ere craniofacial defects if the duration was prolonged to
40 minutes. A slightly higher temperature, 42.5°C for
15 minutes caused craniofacial defects in 100% embryos.25
It may be that during our two week cultivation period,
explants were protected by overexpression of heat shock
proteins followed by induction of growth factor expression,
similarly to the findings reported in mouse tumour develop-
ment.39 Moreover, a positive effect on growth was sug-
gested to arise from the inhibition of protein synthesis of
negative growth regulators.40 However, at the end of cul-
ture, the ability for cell proliferation was lower than in con-
trols, which can be explained by the fact that terminal
differentiation that we find occurs after the exit from the
cell cycle.
Hyperthermia of 42°C for 15 minutes also enhanced dif-
ferentiation of the columnar epithelium and myotubes which
is in concordance with studies on erythroleukaemia cells41
where hyperthermia acted as an inducer of differentiation
while in brain malignant cells it potentiated differentiation
therapy.42 Constitutive heat shock proteins such as HSP70
are present during the mouse myoblast differentiation per-
iod,43 while HSP90 inhibition affected protein kinases regu-
lating pathways required for myoblast differentiation.44
Multiple transduction proteins, which are essential for differ-
entiation, are client proteins of HSP90.45 In porcine satellite
cells, a mild heat shock increased transcription and
TABLE 6 Experimental teratoma differentiation in a long
hyperthermal regime at 40.5°C from the second day of culture. After
the two week culture, differentiation in teratomas was assessed by
classical histology. Note that only the incidence of cartilage was
significantly lower in teratomas cultivated at 40.5°C from the second
day in comparison with controls cultivated at 37°C
Regime
37°C
40.5°C from
second day
CEM43°C (min) Control 585
N % N %
Teratomas developed in vitro 11 100 11 100
Epidermis 11 100 11 100
Neural tissue 9 81.82 10 90.91
Cartilage 9a 81.82 4a 36.36
Myotubes 9 81.82 6 54.55
Columnar epithelium 11 100 10 90.91
Fisher’s exact test: aP < .05.
TABLE 7 Experimental teratoma differentiation in a long
hyperthermal regime at 40.5°C for two weeks. After the two week
culture, differentiation in teratomas was assessed by classical
histology. Note that the incidence of tissues in teratomas cultivated at
40.5°C was similar to the incidence of tissues in controls cultivated at
37°C
Regime
37°C 40.5°C
CEM43°C (min) Control 630
N % N %
Teratomas developed in vitro 9 100 10 100
Epidermis 9 100 10 100
Neural tissue 7 77.78 8 80
Cartilage 8 88.89 7 70
Myotubes 7 77.78 7 70
Columnar epithelium 8 88.89 9 90
140 | KATUSIC BOJANAC ET AL.
translation of HSP90, HSP70, HSP25/27, while in fused
satellite cells, protein synthesis rates were significantly
increased, and degradation rates decreased.46 A treatment of
43°C for 5 minutes causes upregulation of myogenin and
MyHC genes in mouse embryos.47 The higher incidence of
the columnar epithelium in our experiment may also be
related to the expression of thermoprotective heat shock pro-
teins because of their proposed role in differentiation and
development.48 A stronger induction of HSP72 was detected
in gut tissue after 42°C 15-minutes hyperthermia, and the
colon seems to require an enhanced HSP72 response.49
Enhancement of differentiation that we discovered might
also be of interest for regenerative medicine strategies.50
We have to explain that our results on growth and dif-
ferentiation imply that such dysregulation of developmental
processes may lead to teratogenic effects in utero. Although
it was quite difficult to generalize data on teratogenicity
induced by hyperthermia, because of the variety of species
and procedures, it is important to stress that our lowest
CEM43°C 3.75 is slightly above CEM43°C 1-2 minutes
reported to be teratogenic for mammals as reviewed by van
Rhoon et al in 2013.
Although CEM43°C 210 minutes in the regime of 43°C
for 30 minutes each day during the first week is in the
range of CEM43°C 180-240 minutes where ablation of the
prostate cancer was reported, it might be that our
CEM43°C was too low to affect survival because for some
other solid tumours, CEM43°C ˃ 240 was necessary.51
Anyway, the rather unexpected result that the survival was
not at all affected may be explained by the thermotoler-
ance. The short exposure of embryos to the temperature of
42°C could prevent subsequent treatment with severe
hyperthermia of 43°C for 7.5 minutes from causing severe
malformations.25,52 A higher dose, 43°C for 30-60 minutes,
is more teratogenic because it decreases cell proliferation.53
Indeed, 43°C, periodically applied, significantly reduced
the size of explants in our study, similarly as in other
in vitro and in vivo studies at this temperature25,54 and
decreased the ability for cell proliferation (Vv for PCNA).
Obviously, cell cycle dynamics were affected, similarly as
in other in vitro studies on rat embryos.55
Based on the previous research with the metabolically
poor protein-free medium and an embryotoxic sub-
stance,26,27,29,32 our results with the 3 most extreme
regimes discussed below corroborate the idea that in our
model a simple simultaneous assessment of survival and
overall growth endpoints can efficiently screen for the most
deleterious conditions of the microenvironment.
Although 3D systems were less sensitive to tempera-
tures from 37 to 57°C,56 our 3D system treated by the
whole-day regime at 43°C, a 5°C higher temperature than
the normal rat body temperature16 was extremely sensitive.
Melanoma cells at 45°C for 30 minutes (approximate
CEM43°C 120 minutes) produced HSPs and some cells
survived for two weeks,57 while our exposure time of
24 hours at 43°C with the highest CEM43°C 1440 minutes
was probably too severe to elicit HSP production and ther-
motolerance.
The heat was defined as a physical agent that acts
directly on the embryo and seems not to be influenced by
metabolic factors.19,58 Chinese hamster ovary HA-1 cells
have shown that heat sensitivity was not dependent on
serum addition.59 In contrast to that, in chemically defined
medium that we used, with transferrin as the only protein
supplement, deficiency of nutrients seems to have alto-
gether blocked the competitive ability of cells to adapt to
CEM43°C 630 minutes and no survival was detected while
in serum-supplemented medium CEM43°C 630 minutes
several embryos survived.
The last regime with CEM43°C 585 minutes and an
antibody to HSP70 has rendered experimental teratomas
totally unprotected from the heat probably because this anti-
body recognizes both the constitutive (HSC73) and induci-
ble (HSP72) forms of HSP70 that have a protective function
helping the cell to cope with lethal conditions.60 HSPs may
also determine the cell fate by orchestrating the decision of
apoptosis vs differentiation.45 Indeed, in our two week
model apoptosis has been elicited by a chemical agent
already at the beginning of culture when differentiation just
begins (our unpublished observation). Therefore to under-
stand the impact of apoptosis on the overall growth, we
shall do a study in another model of a shorter duration. In
four to eight cell embryos, the addition of anti-HSP70 was
found to reduce development by induction of apoptosis and
degradation of mammalian embryos.61,62 HSP90 inhibitor
caused antiproliferative and apoptotic effect in adult and
paediatric glioblastoma cells in vitro and in vivo.63 Heat
Shock Factor 1 (HSF1), the master regulator of the response
to the heat, in cancer cells has a specific transcriptional sig-
nature that enhances malignancy.64 Inhibition of the HSF1
by an RNA aptamer in cancer cells induced apoptosis and
abolished their colony-forming capability.65 The above
results speak in favour of therapeutic inhibition of the HSPs.
However, extracellularly localized and membrane-bound
HSPs elicit an immunological response against cancer and
are the basis of anticancer vaccines.66 Whether antibodies
against HSPs, sometimes found in the organism of cancer or
other patients, are “a friend or a foe” is questionable.67
Regardless of this dilemma, our result suggests the benefit
of anti-HSP therapy with the therapeutic hyperthermia of
cancer.
The dose of 40.5°C over 2 days (CEM43°C 90 minutes)
was defined as a threshold dose for the development of mal-
formations in 9.5 days old rat embryos in vivo and
in vitro16,68 but was effective even after 40 minutes (approx-
imate CEM43°C 1.25 minutes) when applied to the uterus
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ex vivo.20 In our study, CEM43°C were much higher in
long-term regimes, but the long-term hyperthermia of 40.5°C
caused a more pronounced stage-specific overall growth
inhibition in embryos treated from the second day. In this
organ culture model, differentiation starts from the second
day30; 69, so it is possible that differentiating cells are more
susceptible to the heat shock than undifferentiated, especially
because cell lines vary in response to small temperature ele-
vations.70 Moreover, stem cells express HSPs that protect
them “against external and internal stressors, thereby main-
taining their stemness”71 and that may be the reason that just
explanted embryos were more resistant to the hyperthermia
in our system. Survival was also affected in both groups, but
the ability for cell proliferation at the end of culture remained
the same as in controls. Studies on CHO or Hela cells report
a chronic tolerance and a progression through cell cycle dur-
ing chronic heating at an even higher temperature, 41.5°C.72
The negative effect on cartilage development could be related
to changes in theHox gene expression 19 and skeletal develop-
ment.55,73 It was suggested that a single acute exposure to
42°C be a threshold dose in skeletal development.17 However,
our results support assumption that increasing the duration of
temperature elevation may lower threshold for malformations
to 40-41°C19 as has been recently published for the chick
embryo.74 Other in vitro studies on mammalian skeletal mus-
cle cells have shown that hyperthermia at 41°C for 72 hours
inhibited myotube formation.75
5 | CONCLUSION
Based on the results in our experimental teratoma model,
we may conclude that hyperthermia can directly target the
exact source of stem cells for ectodermal, mesodermal and
endodermal lineages, in a natural 3-dimensional system
reminiscent of a solid tumour. Alongside negative effects
upon survival, growth and cell proliferation in various
regimes, our in vitro screening result with the local short-
term hyperthermia at 42°C applied for 15 minutes
(CEM43°C 3.75) is in line with a rare previous result on
hyperthermal differentiation therapy.41 It should be noted
that the concept of differentiation therapy has been used
for a long time for the treatment of acute promyelocytic
leukaemia.76 Therefore, hyperthermal differentiation ther-
apy may represent a challenging task for future research.
Finally, we may single out our result where the applica-
tion of an antibody against HSP70 before long-term
(13 days) hyperthermia of 40.5°C (CEM43°C 585 minutes)
leads to the total destruction of experimental teratomas that
was not achieved at the same CEM43°C without the anti-
body. A recent study in vivo reduced off-target systemic
tumorigenic effects and distant tumour growth caused by
hyperthermia by an adjuvant HSP inhibition.77 However,
thermal ablation at 60°C for 10 minutes and 90°C for
two minutes far exceeded much milder CEM43°C at a
much milder temperature used in our system that should be
harmless, for example for local application to the skin.
Therefore, our second proposal for the local hyperthermal
therapy strategy in vivo includes the application of an anti-
HSP therapy to avoid thermotolerance elicited by HSPs. It
is also possible that anti-HSPs will destroy tumours in a
shorter time interval because CEM43°C depends linearly
on the heating time interval and exponentially on heating
temperature. This remains to be studied in future in vitro
and in vivo experiments.
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